Preparing for China · patient guide

How to access Rare Disease services at Tongji Hospital in China

Access starts with the hospital's own rare disease or specialist team, not with a booking alone. Confirm which Tongji Hospital campus and department handles your suspected or diagnosed condition, what referral and records they require, and whether an international patient office exists. A records-based review can clarify the next step, but only the treating team decides assessment, admission and treatment.

Go to the practical guidance ↓
AI illustration: A bright office desk with folders, a pen, a coffee mug, notebooks, and a window showing a traditional building outside.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

First establish which Tongji Hospital and which team you need

"Tongji Hospital" is not a single, unambiguous destination for an overseas patient. Tongji Hospital in Wuhan, affiliated with Tongji Medical College of Huazhong University of Science and Technology, and Tongji Hospital in Shanghai, affiliated with Tongji University School of Medicine, are separate institutions in different cities. Both are large tertiary hospitals, and both may have clinicians who see inherited or difficult-to-diagnose conditions, but the departments, referral routes and international-patient arrangements differ. Before any planning, confirm the full hospital name, city and campus from the source that gave you the recommendation.

The second step is identifying the clinical team rather than a general "rare disease service". Rare diseases span genetics, neurology, haematology, immunology, endocrinology, metabolic medicine, rheumatology, cardiology, nephrology and other specialties. A patient with an undiagnosed multisystem problem may need a different entry point from a patient with a known genetic diagnosis and an established care plan. Ask the hospital, or the person referring you, which department accepts your specific problem and whether that department runs a combined or multidisciplinary clinic.

Be cautious with any intermediary who promises a named professor, guaranteed admission or a fixed appointment date before seeing your records. Those are decisions for the hospital. A useful first question is simply: which department at this named hospital reviews records for a patient with this presentation, and what does that department need in order to decide whether an appointment is appropriate?

Rare disease assessment and care planning

What a rare disease referral usually needs to contain

Hospitals assessing complex or rare conditions generally work from a structured clinical summary rather than a pile of unlabelled files. You do not need to send everything at first contact. A short summary should state the main problem, when it began, what has been diagnosed or suspected, which specialists have already been involved, current medicines and the specific question you want answered. That last point matters: "please review my case" is harder to route than "is this progressive neuropathy likely to be hereditary, and are further genetic tests appropriate?"

Supporting records typically include clinic letters, discharge summaries, imaging reports and the actual images where relevant, laboratory results, genetic or pathology reports, and a medication list. For genetic results, the report itself is more useful than a summary line, because the laboratory's classification and the gene and variant details affect interpretation. If a test was done abroad, ask whether the receiving team wants the original report, a translated version, or the raw data.

Translation is a practical issue. Ask the hospital or coordinating service what language the clinical team can review and whether translated summaries are accepted. Keep a copy of everything you send. If records are incomplete, say so rather than waiting indefinitely for a perfect file; the clinical team can tell you what is essential for its own assessment. Do not stop or change any prescribed medicine while gathering documents.

Separate a records review from confirmed hospital acceptance

A records-based opinion and hospital acceptance are different things. A specialist can review your file and comment on the likely diagnosis, the value of further testing, or whether travelling to the hospital is reasonable, while the hospital has not agreed to admit you or to provide a particular treatment. Patients should ask explicitly which of these they have received: an informal comment, a documented second opinion, an invitation to attend an outpatient clinic, or an admission decision.

This distinction is especially important in rare disease. Some conditions have no specific licensed treatment; some treatments exist only within research protocols; some genetic results need confirmation in a certified laboratory; and some diagnoses change after examination and repeat testing. A remote review cannot replace a physical assessment, and it does not establish eligibility for a clinical trial, a transplant programme or access to a particular medicine in China. Those require the relevant programme's own assessment and, where applicable, regulatory and ethics approvals.

Ask the reviewing clinician what remains uncertain and what would change the plan. A useful opinion names the differential diagnoses still in play, the tests that would discriminate between them, and the limits of the evidence reviewed. If you are given a conclusion with no explanation of the evidence behind it, ask for the reasoning in writing.

Questions to ask about tests, medicines and access in China

Rare disease care often depends on tests and products that are not universally available. Rather than assuming that a large Chinese hospital stocks a particular enzyme therapy, orphan medicine or genetic panel, ask the treating team directly. Relevant questions include whether the test or medicine is available at this hospital, whether it must be imported, who is responsible for the application, what approvals are needed, and what the expected timeline depends on. Availability can change, so a written answer from the hospital carries more weight than a general statement that a product is used in China.

For medicines, ask who will prescribe, who will monitor, and how ongoing supply and follow-up would work after you return home. Cross-border transport of medicines, including herbal products, is governed by customs and pharmacy rules; those questions belong to the relevant authorities and dispensing provider, not to a coordinator. Do not assume that a medicine available in your home country can be prescribed, purchased or carried into China, or the reverse.

Genetic and genomic testing deserves its own questions: which laboratory performs the test, whether it is accredited for clinical reporting, what the report will and will not cover, whether family testing is offered, and how variants of uncertain significance will be handled. Whole exome or genome sequencing can generate findings that require specialist interpretation, so ask who will explain the result to you and in what language.

Planning the visit without inventing a timetable

Once a department has indicated that it will see you, practical planning becomes concrete. Confirm the appointment date and time, the campus and building, which clinician or clinic you are booked with, and what you should bring in original form. Ask whether an interpreter is needed and whether the hospital can provide one or whether you must arrange your own. Ask how payment works for registration, consultation, tests and any deposit, and request the written scope of what each payment covers.

Do not rely on a general assumption about how many visits a rare disease assessment takes. Some patients are seen and investigated over several days; others are asked to return after tests; others are referred onward. Ask the clinical team what its usual process is for a patient like you, while accepting that your own course may differ. Similarly, ask how results will be communicated and whether a follow-up appointment will be needed to discuss them, rather than assuming a report will arrive by a particular route.

Travel and visa arrangements are separate from the clinical plan. Apply through the appropriate official channel for your nationality and purpose of travel, and do not treat an appointment letter as a guarantee of entry. Insurance that covers pre-existing conditions, complications and repatriation is worth arranging before travel, and you should check what your policy requires.

Where ChinaSpecialistCare can and cannot help

ChinaSpecialistCare is an information and non-clinical coordination service operated by Suzhou Fenglin International Travel Service Co., Ltd. We can help clarify the patient's main question, identify missing information, and suggest a relevant next step through a free initial case review. Where appropriate, we can request specialist matching and appointment coordination, or arrange a records-based proxy review with a hospital specialist while the patient remains at home. A proxy consultation is optional and is not a prerequisite for an appointment.

For complex cases, a multidisciplinary review involving two or three relevant specialties may be arranged, with the scope and fee agreed first. We can also provide bilingual hospital navigation and interpretation as a separately agreed service. What we cannot do is diagnose, prescribe, decide suitability, guarantee hospital acceptance, confirm that a particular test or medicine is available, or promise an outcome. Those decisions belong to the treating hospital and its licensed clinicians.

A practical next step is to send a brief summary: the suspected or confirmed diagnosis, the main question, key reports and the city and hospital you are considering. From there, the most useful action is usually to confirm the correct Tongji Hospital department and ask what it requires before any travel is booked.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Rare disease assessment and care planning

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.